These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Targeting epigenetic regulators to overcome drug resistance in cancers. Wang N; Ma T; Yu B Signal Transduct Target Ther; 2023 Feb; 8(1):69. PubMed ID: 36797239 [TBL] [Abstract][Full Text] [Related]
4. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy. Morera L; Lübbert M; Jung M Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic Targets and their Inhibitors in Cancer Therapy. Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481 [TBL] [Abstract][Full Text] [Related]
6. Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy. Boila LD; Sengupta A Exp Hematol; 2020 Dec; 92():19-31. PubMed ID: 32950598 [TBL] [Abstract][Full Text] [Related]
7. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review. Sahafnejad Z; Ramazi S; Allahverdi A Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631 [TBL] [Abstract][Full Text] [Related]
8. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges. Gerhauser C Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508 [TBL] [Abstract][Full Text] [Related]
9. An H3K9 methylation-dependent protein interaction regulates the non-enzymatic functions of a putative histone demethylase. Raiymbek G; An S; Khurana N; Gopinath S; Larkin A; Biswas S; Trievel RC; Cho US; Ragunathan K Elife; 2020 Mar; 9():. PubMed ID: 32195666 [TBL] [Abstract][Full Text] [Related]
10. Histone demethylases and their roles in cancer epigenetics. D'Oto A; Tian QW; Davidoff AM; Yang J J Med Oncol Ther; 2016; 1(2):34-40. PubMed ID: 28149961 [TBL] [Abstract][Full Text] [Related]
11. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Cheng Y; He C; Wang M; Ma X; Mo F; Yang S; Han J; Wei X Signal Transduct Target Ther; 2019; 4():62. PubMed ID: 31871779 [TBL] [Abstract][Full Text] [Related]
12. The role of demethylases in cardiac development and disease. Davis K; Azarcon P; Hickenlooper S; Bia R; Horiuchi E; Szulik MW; Franklin S J Mol Cell Cardiol; 2021 Sep; 158():89-100. PubMed ID: 34081951 [TBL] [Abstract][Full Text] [Related]
13. Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets. Bajbouj K; Al-Ali A; Ramakrishnan RK; Saber-Ayad M; Hamid Q Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769131 [TBL] [Abstract][Full Text] [Related]
14. Development of JmjC-domain-containing histone demethylase (KDM2-7) inhibitors for cancer therapy. Zhang L; Chen Y; Li Z; Lin C; Zhang T; Wang G Drug Discov Today; 2023 May; 28(5):103519. PubMed ID: 36754142 [TBL] [Abstract][Full Text] [Related]
15. Mechanistic aspects of reversible methylation modifications of arginine and lysine of nuclear histones and their roles in human colon cancer. Roy A; Niharika ; Chakraborty S; Mishra J; Singh SP; Patra SK Prog Mol Biol Transl Sci; 2023; 197():261-302. PubMed ID: 37019596 [TBL] [Abstract][Full Text] [Related]
19. Targeting histone demethylases as a potential cancer therapy (Review). Diao W; Zheng J; Li Y; Wang J; Xu S Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35801593 [TBL] [Abstract][Full Text] [Related]